Dr. Michael P. Collini, MD
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Baylor College of Medicine (1992)
- Years since graduation
- 34
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 48
Licensed in Texas since 1994, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1992Medical school: Baylor College of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
TX license J5557 (first issued 1994; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Texas Health Harris Methodist Hospital Southwest F Fort Worth, TX
- Usmd Hospital at Arlington L P Arlington, TX
Medical groups
- Urology PArtners of North Texas, PLLC (92 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 48
- Services billed
- 132
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Psa (prostate specific antigen) measurement, total | 56 | 55 |
| Insertion of needle into vein for collection of blood sample | 52 | 50 |
| Injection of biodegradable material next to prostate | 17 | 17 |
| Placement of device in prostate for radiation therapy | 17 | 17 |
| Ultrasonic guidance for needle placement | 17 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Fort Worth, TX | 27 |
| Tamsulosin Hcl Other prescribers in Fort Worth, TX | 25 |
| Finasteride Other prescribers in Fort Worth, TX | 17 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 6 payments worth $490 in total to this clinician.
| Urogen Pharma, Inc. | $119 |
|---|---|
| Intuitive Surgical, Inc. | $113 |
| Janssen Biotech, Inc. | $102 |
| Procept Biorobotics Corporation | $81.31 |
| Olympus America Inc. | $73.31 |
| Food and Beverage | $490 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $117,070 in research payments for these studies, mostly to the institutions running them.
- RESTORE: An RCT to Evaluate the Efficacy of the Revi System
Bluewind Medical · Active, not recruiting · NCT06217328
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.